Skip to main content

Advertisement

Log in

Juvenile localised scleroderma: a retrospective review of response to systemic treatment

  • Original Article
  • Published:
Irish Journal of Medical Science Aims and scope Submit manuscript

Abstract

Background

Juvenile localised scleroderma (JLS) is a rare connective tissue disorder in childhood. Most lesions are benign and self-limiting, but some progress to cause functional disabilities and cosmetic disfigurement. These lesions require systemic treatment, the mainstay of which is corticosteroids and methotrexate.

Aim

To report the experience of the use of systemic treatment in children with JLS in our department.

Methods

We performed a retrospective chart review looking at the patients who received systemic treatment over 14 years and recorded their outcomes.

Results

Ten children with aggressive JLS were treated with systemic immunosuppressive therapy. There was an 80% response to treatment. Three of the responders relapsed off treatment, but responded to a further course of therapy. Mean disease duration at diagnosis was 8 months. Treatment was generally well tolerated with few side effects.

Conclusion

Early recognition of aggressive localised scleroderma and appropriate referral is imperative for a good outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Uziel Y, Feldman BM, Krafchik BR et al (2000) Methotrexate and corticosteroid treatment for pediatric localized scleroderma. J Pediatr 136:91–95. doi:10.1016/S0022-3476(00)90056-8

    Article  PubMed  CAS  Google Scholar 

  2. Weibel L, Sampaio MC, Visentin MT et al (2006) Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma in children. Br J Dermatol 155(5):1013–1020. doi:10.1111/j.1365-2133.2006.07497.x

    Article  PubMed  CAS  Google Scholar 

  3. Zulian F, Athreya BH, Laxer R et al (2006) Juvenile Localized Scleroderma: clinical and epidemiological features in 750 children. Rheumatology 45(5):614–620. doi:10.1093/rheumatology/kei251

    Article  PubMed  CAS  Google Scholar 

  4. Zulian F, Vallongo C, Woo P et al (2005) Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum 52:2873–2881. doi:10.1002/art.21264

    Article  PubMed  Google Scholar 

  5. Kreuter A, Hyun J, Stücker M et al (2006) Randomized controlled study of low-dose UVA1, medium dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma. J Am Acad Dermatol 54(3):440–447. doi:10.1016/j.jaad.2005.11.1063

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. Cox.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cox, D., O’ Regan, G., Collins, S. et al. Juvenile localised scleroderma: a retrospective review of response to systemic treatment. Ir J Med Sci 177, 343–346 (2008). https://doi.org/10.1007/s11845-008-0217-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-008-0217-0

Keywords

Navigation